ZEPOSIA

The mark consists of the word "ZEPOSIA" in dark blue with a triangle design in gray, blue and red to the left.

Mark For: ZEPOSIA® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system. [all]

>The color(s) blue, gray, and red is/are claimed as a feature of the mark. The mark consists of the word "ZEPOSIA" in dark blue with a triangle design in gray, blue and red to the left.

Status

2020-01-15 UTC
⟳ Refresh

LIVE APPLICATION Under Examination

Research	OneLook Acronym Finder
Serial Number	88696906
Registration Number	6584117
Mark Literal Elements	ZEPOSIA
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED 2020-01-06
Basis	1(b) 44(d)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	Yes
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Camille M. Miller
Attorney Docket Number	CELG-2069US/
Law Office Assigned	L40
Employee Name	MARTIN, CHRISTINE C

Timeline

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system